PALVELLA THERAPEUTICS, INC. 8-K

What Happened
Palvella Therapeutics, Inc. announced on January 29, 2026 (via Form 8-K, Item 8.01) that it posted a corporate presentation to its website. The presentation was filed with the SEC as Exhibit 99.1 and the Form 8-K was signed by Chief Financial Officer Matthew Korenberg on January 29, 2026.

Key Details

• Filing date: January 29, 2026 (Form 8-K, Item 8.01).
• Exhibit: Corporate Presentation filed as Exhibit 99.1.
• Purpose: Presentation will be used by company representatives in investor meetings from time to time.
• Signature: Report signed by Matthew Korenberg, CFO.

Why It Matters
Corporate presentations provide an official source of the company’s messaging to investors—covering strategy, clinical programs, milestones, timelines, or financial highlights. Because Palvella has made this presentation public and filed it with the SEC, investors can review it on the company website or EDGAR to see the most current information the company is presenting to the market.